| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |